TG Therapeutics Inc (TGTX)
Inventory turnover
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cost of revenue (ttm) | US$ in thousands | 192,785 | 177,271 | 162,242 | 145,863 | 133,962 | 117,671 | 95,647 | 77,570 | 70,111 | 80,019 | 100,664 | 122,043 | 101,520 | 112,914 | 113,311 | 93,728 | 107,850 | 68,247 | 36,265 | 24,547 |
| Inventory | US$ in thousands | 110,458 | 84,669 | 81,243 | 77,719 | 39,823 | 33,553 | 30,234 | 27,221 | 0 | — | -32,451 | 4,092 | -23,604 | -13,507 | -5,029 | 5,590 | — | — | — | — |
| Inventory turnover | 1.75 | 2.09 | 2.00 | 1.88 | 3.36 | 3.51 | 3.16 | 2.85 | — | — | — | 29.82 | — | — | — | 16.77 | — | — | — | — |
December 31, 2024 calculation
Inventory turnover = Cost of revenue (ttm) ÷ Inventory
= $192,785K ÷ $110,458K
= 1.75
TG Therapeutics Inc's inventory turnover has fluctuated significantly over the periods reported. The company did not provide data for the inventory turnover for most of 2020 and the first half of 2021. However, as of March 31, 2021, the inventory turnover was 16.77, indicating the company was selling through its inventory almost 17 times during that period.
Subsequently, there was a substantial increase in inventory turnover to 29.82 by March 31, 2022, suggesting more efficient management of inventory or potentially higher sales volume relative to the level of inventory held.
However, the inventory turnover dipped significantly by the end of March 2023 to 2.85, indicating a slowdown in inventory turnover. This trend continued with slight upticks in subsequent quarters, reaching 2.09 by September 30, 2024. The latest reported inventory turnover for December 31, 2024, stood at 1.75.
The declining inventory turnover from the peak in March 2022 to the end of 2024 could signify potential issues such as overstocking, slowing sales, or inefficient inventory management. Further analysis of operational and sales data would be necessary to fully understand the reasons behind this downward trend and its implications for TG Therapeutics Inc.
Peer comparison
Dec 31, 2024
Dec 31, 2024